Literature DB >> 2468688

Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration.

E N Charlesworth1, A F Hood, N A Soter, A Kagey-Sobotka, P S Norman, L M Lichtenstein.   

Abstract

To better define the inflammatory infiltrates and kinetics of mediator release during the cutaneous late-phase reaction (LPR), we examined skin biopsies at 8 h, and skin chamber cell counts and mediator release for 12 h after antigen challenge. Compared with the control sites, the antigen-stimulated biopsy sites contained 14 times as many basophils (P less than 0.01) and six times as many eosinophils (P less than 0.001) with one to two fold more mononuclear cells (P less than 0.03) and neutrophils (P less than or equal to 0.01). Similar changes were found in the skin chambers. Although there were neutrophils in the control chamber, they were only twice as numerous in the antigen challenged site (P less than 0.01). Eosinophils were 35-fold (P less than or equal to 0.03) more prevalent in the antigen chamber than the control chamber for hours 8-12 and basophils were noted starting in the eighth hour and were 20-fold (P less than or equal to 0.03) more concentrated in the antigen chamber during the next 4 h. The mononuclear cells were not significantly different between antigen and control blisters. With respect to inflammatory mediators, there was an initial peak of histamine (13.2 +/- 2.9 ng/ml) in the blister fluid at 1 h. The level then fell to approximately 2 ng/ml, followed by a secondary rise starting at the eighth hour and increasing to 9.8 +/- 2.8 ng/ml by the twelfth hour. This secondary increase in histamine correlated significantly (r = 0.81, P less than 0.05) with the observed influx of basophils. PGD2 in the blister fluid rose to 371+/-25 pg/ml during the first 4 h and then slowly decreased to half this level during the last 4 h. Thus, the cutaneous LPR has been shown to manifest a secondary increase in histamine levels and a markedly specific increase in eosinophils and basophils with mediator release apparently being derived from the latter cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2468688      PMCID: PMC303856          DOI: 10.1172/JCI114047

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  46 in total

1.  The late phase skin reaction: evidence for activation of the coagulation system in an IgE-dependent reaction in man.

Authors:  R D deShazo; A I Levinson; H F Dvorak; R W Davis
Journal:  J Immunol       Date:  1979-02       Impact factor: 5.422

2.  Distribution of mast cells in human dermis: development of a mapping technique.

Authors:  T Cowen; P Trigg; R A Eady
Journal:  Br J Dermatol       Date:  1979-06       Impact factor: 9.302

3.  Dual skin test reactions and serum antibodies to subtilisin and Aspergillus fumigatus extracts.

Authors:  O Zetterström
Journal:  Clin Allergy       Date:  1978-01

Review 4.  Cyclic nucleotides, prostaglandins and polyamines in psoriasis.

Authors:  C L Marcelo; J J Voorhees
Journal:  Pharmacol Ther       Date:  1980       Impact factor: 12.310

5.  Cytotoxic properties of the eosinophil major basic protein.

Authors:  G J Gleich; E Frigas; D A Loegering; D L Wassom; D Steinmuller
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

6.  Prostaglandin D2 and histamine during the immediate and the late-phase components of allergic cutaneous responses.

Authors:  M M Pienkowski; N F Adkinson; M Plaut; P S Norman; L M Lichtenstein
Journal:  J Allergy Clin Immunol       Date:  1988-07       Impact factor: 10.793

7.  The direct demonstration of histamine release in allergic reactions in the skin using a skin chamber technique.

Authors:  E H Dunsky; B Zweiman
Journal:  J Allergy Clin Immunol       Date:  1978-08       Impact factor: 10.793

8.  Mast cell population density, blood vessel density and histamine content in normal human skin.

Authors:  R A Eady; T Cowen; T F Marshall; V Plummer; M W Greaves
Journal:  Br J Dermatol       Date:  1979-06       Impact factor: 9.302

9.  Nasal challenge testing in grass pollen hay fever.

Authors:  M J Schumacher; M C Pain
Journal:  J Allergy Clin Immunol       Date:  1979-09       Impact factor: 10.793

10.  Elevated levels of the eosinophil granule major basic protein in the sputum of patients with bronchial asthma.

Authors:  E Frigas; D A Loegering; G O Solley; G M Farrow; G J Gleich
Journal:  Mayo Clin Proc       Date:  1981-06       Impact factor: 7.616

View more
  24 in total

Review 1.  Basophils in airway disease.

Authors:  Donald MacGlashan; Gail Gauvreau; John T Schroeder
Journal:  Curr Allergy Asthma Rep       Date:  2002-03       Impact factor: 4.806

2.  Eosinophil granule proteins expressed in ocular cicatricial pemphigoid.

Authors:  A Heiligenhaus; J Schaller; S Mauss; S Engelbrecht; J E Dutt; C S Foster; K P Steuhl
Journal:  Br J Ophthalmol       Date:  1998-03       Impact factor: 4.638

3.  Quantification of inflammatory mediators in stool samples of patients with inflammatory bowel disorders and controls.

Authors:  S C Bischoff; J Grabowsky; M P Manns
Journal:  Dig Dis Sci       Date:  1997-02       Impact factor: 3.199

4.  Effects of an Oral CRTh2 Antagonist (AZD1981) on Eosinophil Activity and Symptoms in Chronic Spontaneous Urticaria.

Authors:  Eric Tyrell Oliver; Kris Chichester; Kelly Devine; Patricia Meghan Sterba; Craig Wegner; Becky Marie Vonakis; Sarbjit Singh Saini
Journal:  Int Arch Allergy Immunol       Date:  2019-03-15       Impact factor: 2.749

5.  Mucosal pathophysiology and inflammatory changes in the late phase of the intestinal allergic reaction in the rat.

Authors:  P C Yang; M C Berin; L Yu; M H Perdue
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

6.  IL-9(+) IL-10(+) T cells link immediate allergic response to late phase reaction.

Authors:  S-H He; Z-Q Liu; X Chen; C-H Song; L-F Zhou; W-J Ma; L Cheng; Y Du; S-G Tang; P-C Yang
Journal:  Clin Exp Immunol       Date:  2011-04-13       Impact factor: 4.330

7.  Stability of Syk protein and mRNA in human peripheral blood basophils.

Authors:  Donald MacGlashan
Journal:  J Leukoc Biol       Date:  2016-03-15       Impact factor: 4.962

Review 8.  "Siglec"ting the allergic response for therapeutic targeting.

Authors:  Bruce S Bochner
Journal:  Glycobiology       Date:  2016-02-23       Impact factor: 4.313

9.  Allergen-stimulated T lymphocytes from allergic patients induce vascular cell adhesion molecule-1 (VCAM-1) expression and IL-6 production by endothelial cells.

Authors:  Y Delneste; P Jeannin; P Gosset; P Lassalle; E Cardot; I Tillie-Leblond; M Joseph; J Pestel; A B Tonnel
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

10.  Effects of FK506 and cyclosporin A on proliferation, histamine release and phenotype of murine mast cells.

Authors:  N Toyota; Y Hashimoto; S Matsuo; Y Kitamura; H Iizuka
Journal:  Arch Dermatol Res       Date:  1996-07       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.